Neuroblastoma is a childhood cancer that develops when immature nerve cells fail to develop into normal mature nerve cells. These tumors can begin anywhere in the body, but are often found in the abdomen or chest, neck, hips, and bone marrow. Despite intensive chemotherapy, neuroblastoma can be difficult to cure and the prognosis is often […]
Pfizer, a pharmaceutical company, in partnership with BioNTech has reported that its lead vaccine candidates has shown promising results in protecting monkeys against coronavirus infections. Pfizer ‘s experimental vaccine is different from other vaccine candidates. This is in an mRNA format, which should allow for a better migration of the viral gene into the cell […]
On August 24, PNAS – A very high risk of COVID 19 infection in primate species has been reported. Their analysis predicts that several critically endangered primate species are at very high risk of the virus, although the results need to be confirmed with further experiments or surveillance. An international team of scientists has assessed […]
We were pleased to be invited by Nancy C. Caralla of the C Diff Foundation to this important discussion on the Voice America Radio Network about how Microbiome functions and how its changes impact our health. Join us with our guest: Dr. Candida Fratazzi, Consulting Medical Director at Vedanta Biosciences, focused on pioneering rational design […]
Patients with mild COVID 19 infection, from a variety of age groups, were still experiencing major symptoms for months after COVID 19 disease is over. Read full article: https://jamanetwork.com/journals/jama/fullarticle/2768351 The Jama study was conducted in 143 COVID 19 patients. The mean age was 56.5 (SD, 14.6) years (range, 19-84 years), and 53 (37%) were women. […]
SARS-CoV-2 outbreaks that cannot be explained by large droplets and contact with surfaces alone. Droplets from speech can float in air for eight minutes. A growing body of evidence suggests beyond any reasonable doubt that the virus spreads indoors through tiny aerosols—a finding that should be reflected in the WHO’s recommendations. Like the flu, COVID-19 […]
Preliminary data suggest that survivors of SARS-CoV-2 infection may be susceptible to reinfection within weeks or months. One study in ~1,500 COVID patients show that 10 percent % of these patients had undetectable antibody levels within weeks of first symptoms or lost their antibodies two to three months after recovering from the infection. Early works […]
At least 28 communities living in extreme isolation in the Brazilian Amazon, and there may be as many as 80 more, have confirmed to be in existence. On April 9, a Yanomami adolescent had died of COVID-19 in the northern state of Roraima. The youth had moved back and forth through an area rife with […]
A pilot study in China in which seven COVID-19 patients received intravenous infusions of donor mesenchymal stem cells (MSC) indicates that the intervention was safe, and that the approach may improve infection outcomes was reported in Aging and Disease last month. We understand that it is only a small number of cases, and studies in […]
Four vaccine candidates—two in the US, one in China, and one in the UK—have been approved for early testing in people. Many others are also following. Researchers look to messenger RNA encased in nanoparticles, DNA plasmids, molecular clamps, and other approaches as they rush to design a vaccine against the new coronavirus. Inovio to develop […]